Stability of visual acuity improvement following discontinuation of amblyopia treatment in children aged 7 to 12 years

Archives of Ophthalmology

Volumn 125, Issue 5, 2007, Pages 655-659

  Hertle, Richard W ^a   Scheiman, Mitchell M ^b   Beck, Roy W ^b   Chandler, Danielle L ^b   Bacal, Darron A ^b   Birch, Eileen ^b   Chu, Raymond H ^b   Holmes, Jonathan M ^b   Klimek, Deborah L ^b   Lee, Katherine A ^b   Repka, Michael X ^b   Weakley Jr , David R ^b  

^a JAEB CENTER FOR HEALTH RESEARCH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE;

AMBLYOPIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCHOOL CHILD; SPECTACLES; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; VISUAL ACUITY;

AMBLYOPIA; ATROPINE; CHILD; EYEGLASSES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROSPECTIVE STUDIES; SENSORY DEPRIVATION; VISUAL ACUITY; WITHHOLDING TREATMENT;

EID: 34248538433     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.125.5.655     Document Type: Article

References (13)

1. Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2002;120:268-278.
2. Pediatric Eye Disease Investigator Group. A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol. 2003;121:603-611.
3. Pediatric Eye Disease Investigator Group. A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology. 2003;110:2075-2087.
4. Pediatric Eye Disease Investigator Group. A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology. 2004;111:2076-2085.
5. Kushner BJ. Functional amblyopia: a purely practical pediatric patching protocol. In: Ophthalmology Annual. New York, NY: Raven Press; 1988:173-198.
6. Rutstein RP, Fuhr PS. Efficacy and stability of amblyopia therapy. Optom Vis Sci. 1992;69:747-754.
7. Levartovsky S, Gottesman N, Shimshoni M, Oliver M. Factors affecting longterm results of successfully treated amblyopia: age at beginning of treatment and age at cessation of monitoring. J Pediatr Ophthalmol Strabismus. 1992;29:219-223.
8. Flynn JT, Woodruff G, Thompson JR, et al. The therapy of amblyopia: an analysis comparing the results of amblyopia therapy utilizing two pooled data sets. Trans Am Ophthalmol Soc. 1999;97:373-390.
9. Pediatric Eye Disease Investigator Group. Risk of amblyopia recurrence after cessation of treatment. J AAPOS. 2004;8:420-428.
10. Mohan K, Saroha V, Sharma A. Successful occlusion therapy for amblyopia in 11- to 15-year-old children. J Pediatr Ophthalmol Strabismus. 2004;41:89-95.
11. Leiba H, Shimshoni M, Oliver M, Gottesmann N, Levartovsky S. Long-term follow-up of occlusion therapy in amblyopia. Ophthalmology. 2001;108:1552-1555.
12. Pediatric Eye Disease Investigator Group. Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol. 2005;123:437-447.
13. Cotter SA, Chu RH, Chandler DL, et al. Reliability of the Electronic Early Treatment Diabetic Retinopathy Study testing protocol in children 7 to <13 years old. Am J Ophthalmol. 2003;136:655-661.